Relapse of Type A -Lactamase-Producing Staphylococcus aureus Native Valve Endocarditis during Cefazolin Therapy: Revisiting the Issue
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Our experience with a patient with methicillin-susceptible Staphylococcus aureus aortic native valve endocarditis, who had a relapse involving fever and positive blood culture results while receiving cefazolin, led us to evaluate this organism's ability to hydrolyze cefazolin at high inocula, a previously well-documented phenomenon. Analysis of the infecting strain disclosed a high minimum inhibitory concentration of cefazolin when a large inoculum was used, as well as rapid and complete cefazolin degradation, which was associated with regrowth in a time-kill experiment. DNA sequencing of the beta-lactamase gene showed that it was identical to that of the S. aureus type A beta-lactamase, known to efficiently inactivate cefazolin. A word of caution is given regarding the use of this antibiotic for treatment of endocarditis caused by this type of S. aureus isolate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Preparation of Genomic DNA from Bacteria
Wilson, K. (2001) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb0204s56 · Cited by 2,082 · cited 1×
“Genomic DNA was extracted by the hexadecyltrimethyl ammonium bromide method, as described elsewhere [13, 14], except for the addition of lysostaphin (5 U/mL; Sigma Chemicals).”
MethodSimplified, Accurate Method for Antibiotic Assay of Clinical Specimens
Bennett, J. V., Brodie, J. L., Benner, E. J., & Kirby, W. (1966) · Applied Microbiology · doi:10.1128/aem.14.2.170-177.1966 · Cited by 955 · cited 1×
“Cefazolin concentrations were determined by agar-well diffusion bioassay using Bacillus subtilis in triplicates [11].”
MethodWilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492
Pacemaker infective endocarditis
Cacoub, P., Leprince, P., Nataf, P., Hausfater, P., Dorent, R., Wechsler, B., Bors, V., Pavie, A., Piette, J. C., & Gandjbakhch, I. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00365-8 · Cited by 314 · cited 1×
“with intracardiac leads [18], did not reveal any vegetations”
BackgroundWilson, W. R. (1995) · JAMA · doi:10.1001/jama.274.21.1706 · Cited by 288
Malathum, K., Singh, K. V., Weinstock, G. M., & Murray, B. E. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.211-215.1998 · Cited by 104 · cited 1×
“Genomic DNA was extracted by the hexadecyltrimethyl ammonium bromide method, as described elsewhere [13, 14], except for the addition of lysostaphin (5 U/mL; Sigma Chemicals).”
MethodSelf-citationCharacterization of four beta-lactamases produced by Staphylococcus aureus
Zygmunt, D. J., Stratton, C. W., & Kernodle, D. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.440 · Cited by 102 · cited 1×
“However, we should also point out that cefazolin is relatively stable in the presence of type B and C b-lactamases [5] and that clinical cefazolin failures associated with S.”
BackgroundFailure of Cephalosporins to Prevent Staphylococcus aureus Surgical Wound Infections
Kernodle, D. S., Classen, D. C., Burke, J. F., & Kaiser, A. B. (1990) · JAMA · doi:10.1001/jama.1990.03440070049031 · Cited by 97 · cited 1×
“aureus strains producing a large amount of type A b-lactamase [10, 20].”
BackgroundUnsuccessful Treatment of Staphylococcal Endocarditis With Cefazolin
Bryant, R. E. (1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03270330059022 · Cited by 86 · cited 2×
“This report was followed by another report of 2 patients who experienced therapeutic failure while receiving the same low dose of cefazolin, 1 of whom had CNS involvement [7].”
BackgroundDifferentiation of -Lactamase Variants of Staphylococcus aureus by Substrate Hydrolysis Profiles
Kernodle, D. S., Stratton, C. W., Mcmurray, L. W., Chipley, J. R., & Mcgraw, P. A. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.1.103 · Cited by 73 · cited 2×
“aureus strains that produce a large amount of type A b-lactamase [2, 3].”
BackgroundClinical Experiences with Cefazolin and Other Cephalosporins in Bacterial Endocarditis
Quinn, E. L., Pohlod, D., Madhavan, T., Burch, K., Fisher, E., & Cox, F. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_2.s386 · Cited by 68 · cited 4×
“aureus isolates, including high MICs of cefazolin when a large inoculum was used, which was also associated with cefazolin degradation [6].”
BackgroundMethodInfluentialVoladri, R. K. R., & Kernodle, D. S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3163 · Cited by 57 · cited 3×
“DNA sequencing of the amplified product from the TX0117 strain showed an identical nucleotide sequence to that previously reported for the type A b-lactamase gene [4, 16].”
BackgroundResultWang, P. Z., & Novick, R. P. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.4.1763-1766.1987 · Cited by 57
Kernodle, D. S., McGraw, P. A., Stratton, C. W., & Kaiser, A. B. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.3.420 · Cited by 53 · cited 3×
“aureus strains that produce a large amount of type A b-lactamase [2, 3].”
BackgroundExperience with Cefazolin: An Overall Summary of Pharmacologic and Clinical Trials in Man
Gold, J. A., McKee, J. J., & Ziv, D. S. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_2.s415 · Cited by 52 · cited 1×
“5 mg/mL at 4 h [25], the concentration of this antibiotic in the depth of a”
BackgroundGoldman, P. L., & Petersdorf, R. G. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/141.3.331 · Cited by 36
Staphylococcal -Lactamase and Efficacy of -Lactam Antibiotics: In Vitro and in Vivo Evaluation
Chapman, S. W., & Steigbigel, R. T. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.6.1078 · Cited by 33
Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis
Tomayko, J. F., Zscheck, K. K., Singh, K. V., & Murray, B. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1170 · Cited by 31 · cited 1×
“Primers to amplify an ∼850-bp region of the structural gene were blaZ 1F 5′-TACAACTGTAATATCGGAGGG-3′ and blaZ 1R 5′-CATTACACTCTTGGCGGTTTC-3′, and other previously described blaZ intragenic primers [15] were used to confirm the sequence of both strands.”
MethodSelf-citationKernodle, D. S., Classen, D. C., Stratton, C. W., & Kaiser, A. B. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.219-222.1998 · Cited by 30 · cited 2×
“aureus strains producing a large amount of type A b-lactamase [10, 20].”
BackgroundMethodAntistaphylococcal Activity and -Lactamase Resistance of Newer Cephalosporins
Farrar, W. E., & Gramling, P. K. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/133.6.691 · Cited by 27 · cited 1×
“We evaluated this characteristic, determining MICs with different inoculum sizes, which depicted the classical inoculum effect well-known for b-lactamases [17].”
MethodEvaluation of Cefazolin in the Treatment of Bacterial Endocarditis and Bacteremia
Reinarz, J. A., Kier, C. M., & GUCKIAN, J. C. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_2.s392 · Cited by 20 · cited 1×
“[19], however, reported successful cefazolin treatment of S.”
Result[6] Immunological techniques for studying β-lactamases
Richmond, M. H. (1975) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(75)43082-8 · Cited by 14 · cited 1×
“by immunologic methods [1], later by their rate of”
MethodCarrizosa, J., Kobasa, W. D., Snepar, R., Kaye, K. M., & Kaye, D. (1982) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/9.5.387 · Cited by 13 · cited 2×
“Presumed residual b-lactamase activity was inactivated by heat (85 C for 30 s) before the bioassay was performed [12]; we confirmed that heat treatment of the sample does not affect the antibiotic concentration.”
MethodResultCefazolin and Staphylococcus aureus Endocarditis
Hewitt, W. L. (1977) · JAMA · doi:10.1001/jama.1977.03270510023006 · Cited by 11 · cited 1×
“However, others have defended the role of cefazolin in the treatment of staphylococcal endocarditis on the basis of personal and general—albeit largely unpublished— experience [8].”
BackgroundBruns, W., & Keppeler, H. (1987) · Journal of Medical Microbiology · doi:10.1099/00222615-23-2-133 · Cited by 7 · cited 1×
“The number of organisms inside an infected vegetation may be as high as 10(10) cfu/g of tissue, and, considering that up to 50% of the b-lactamase can be excreted from the bacterial cells [24], the concentration of this enzyme inside the vegetation might reach substantial proportions.”
Background
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Clinical management of Staphylococcus aureus bacteraemia
Thwaites, G. E., Edgeworth, J. D., Gkrania-Klotsas, E., Kirby, A., Tilley, R., Török, M. E., Walker, S., Wertheim, H. F., Wilson, P., & Llewelyn, M. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70285-1 · Cited by 261
Update on Infective Endocarditis
Bashore, T. M., Cabell, C., & Fowler, Jr. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2005.12.001 · Cited by 227
Nannini, E. C., Stryjewski, M. E., Singh, K. V., Bourgogne, A., Rude, T. H., Corey, G. R., Fowler, V. G., & Murray, B. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00317-09 · Cited by 160
“As previously reported (14), no increases in the cefazolin MIC at HI were observed with the Bla-negative strain ATCC 25923, while a slight increase (to 4 g/ml) was seen with the weak type A Bla producer ATCC 29213.”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Nannini, E. C., Singh, K. V., & Murray, B. E.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Murray, B. E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 37
- Issue
- 9
- Pages
- 1194-1198
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2137030105
- Cited by
- 103
- References
- 26
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 8 · 2014: 8 · 2013: 3 · 2012: 3
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- Staphylococcus aureus, native valve endocarditis, aortic valve endocarditis, cefazolin, beta-lactamase, antibiotic resistance, minimum inhibitory concentration, time-kill kinetics, beta-lactamase genes, antibiotic treatment failure
- MeSH terms
- Anti-Bacterial Agents, beta-Lactamases, Cefazolin, Endocarditis, Bacterial, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Recurrence, Staphylococcal Infections, Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.